Archives of Ophthalmology · 1982 · 68 citations · 3 references
MedicineOphthalmologyPharmacologyOcular DiseaseOcular PharmacologyOphthalmic Drug DeliveryCannabinoid PharmacologyCannabinoid ToxicologyOcular IrritationOcular PharmacodynamicsOcular ToxicologyTopical Ocular Drug DeliveryAdverse Ocular EffectsDelta-9-tetrahydrocannabinol ToxicologyDrug-induced MydriasisDrug-induced Ocular IrritationDrug-induced Ocular ToxicityOcular Drug ToxicitySystemic Adverse Effectsδ9-Tetrahydrocannabinol Toxicity
delta 9-Tetrahydrocannabinol (THC) or vehicle alone was applied topically to one eye of normal paid volunteers. Ocular and systemic toxic effects and intraocular responses were measured in different series. Toxicity was limited to minor conjunctival injection that was of short (less than 60 minutes) duration and occurred with both drug and vehicle alone. Subjective responses indicated a sensation of minor burning and/or tearing. No fall in intraocular pressure was found. A small (1 mm) but significant mydriasis occurred in both the treated eye and untreated eye and was not drug related. Single-drop administration of delta 9-THC did not, therefore, cause any significant ocular irritation or reduce IOP.
3
Cannabinoid penetration and chronic effects in the eye
Keith Green, John F. Bigger, Keun Kim et al. · Experimental Eye Research · 1977 · 39 citations
Nabilone: A Pressure-Reducing Synthetic Benzopyran in Open-Angle Glaucoma
Frank W. Newell, Paul Stark, Walter M. Jay et al. · Ophthalmology · 1979 · 29 citations